What Pfizer, Trump and Consumers Got Out of a Surprising Deal - And What They Didn't - Stat News
Mike Strazzella, Practice Group Leader of Buchanan's Federal Government Relations practice and head of the firm's Washington D.C. office, comments on President Trump's and Pfizer's recent interactions that led to a temporary decrease in drug pricing in Stat News' article "What Pfizer, Trump and Consumers Got Out of a Surprising Deal - And What They Didn't."
Contributors
Related Services & Industries